eshre

Presented in partnership with Fertility and Sterility onsite at the 2023 ESHRE 39th Annual Meeting in Copenhagen.

To date, recurrent implantation failure (RIF) has no clear definition and no clearly identified impaired function. Hence, the term RIF is currently used somewhat haphazardly, on the basis of clinicians’ judgment. International experts in reproductive medicine met on July 1, 2022, in Lugano, Switzerland, to review the different facets of RIF and define the diagnosis and its appropriate management. This Journal Club Global, recorded on June 27, 2023 at the ESHRE conference, discusses the consensus statement from that meeting. Panelists include Eve Feinberg, MD, Dominique de Ziegler, MD, Paul Pirtea, MD, Anne Steiner, MD, Baris Ata, MD, MCT, and Edgardo Somigliana, MD, PhD.

This month's Fertility & Sterility is live from ESHRE 2022 in Milan, Italy! Listen to interviews from a few of the presenters. Topics in Part 1 include Apps for TIC (3:14), AI for cycle optimization (11:26), Time-lapse imaging (11:35), Poor quality embryo transfer (26:16), Embryo morphokenetics & ploidy status (33:36), 3rd party origin children’s book (39:54), 3D Embyro Construction (43:54), Pregnancy after breast cancer (53:03), and Evaluation of the Duostim protocol (57:44).

View Fertility and Sterility at https://www.fertstert.org/

This month's Fertility & Sterility is live from ESHRE 2022 in Milan, Italy! Listen to interviews from a few of the presenters. Topics in Part 2 include a conversation with Rick LeGrow (1:01), Route of Progesterone administration (6:26), Thyroid hormone replacement (16:12), A discussion about ICMART (21:12), Endometriosis testing in blood (28:26), Ovarian stimulation and subsequent breast cancer (35:34), Semen analysis tests comparison (39:48) and Evacuating embryos from Ukraine (43:30).

View Fertility and Sterility at https://www.fertstert.org/

This Journal Club Global discusses a provocative article recently published in Fertility and Sterility Reviews. The study's objective was to identify models predicting live birth or ongoing pregnancy in couples with unexplained recurrent pregnancy loss (RPL), and to evaluate the risk of bias, performance, generalizability, and applicability of these models.
 
The study is presented by Dr. Henriette Svarre Nielsen (University of Copenhagen). Additional discussants include experts in new ART developments, including the lead author of the article, Dr. Angelos Youssef (Leiden University Medical Center). The event is moderated by Dr. Paul Pirtea (Foch Medical Center – UVSQ), along with F&S Editorial Editors Drs. Dominique De Ziegler and Eve Feinberg.

Link to article: https://www.fertstertreviews.org/article/S2666-5719(22)00002-0/fulltext

View Fertility and Sterility at https://www.fertstert.org/

On this episode of ASRM Today, Eve Feinberg discusses the Joint Statement issued by the American Society for Reproductive Medicine (ASRM), the European Society of Human Reproduction and Embryology (ESHRE), and the International Federation of Fertility Societies (IFFS) concerning the global COVID-19 pandemic. Dr. Eve Feinberg is the president of the Society for Reproductive Endocrinology and Infertility (SREI), and an associate editor for the journal, Fertility and Sterility. She sits on both the Executive Board of the American Collegee of Obstetricians and Gynecologists (ACOG) as well as the ASRM.

To view all of ASRM's resources on COVID-19, please visit https://www.asrm.org/COVID-19

The ASRM Today podcast is supported in part by the ASRM Corporate Member Council.